Structura Biotechnology is unlocking the potential of cryo-EM as a high-throughput structure determination technique for life sciences and drug discovery. We develop cutting-edge computational methods and software that power cryo-EM structure determination at scale. Our flagship platforms — CryoSPARC™ and CryoSPARC Live™ — deliver high-resolution 3D reconstructions and real-time data analysis, accelerating research on membrane proteins, GPCRs, and other critical drug targets. Trusted by leading academic labs and pharmaceutical companies worldwide, Structura is pushing the boundaries of cryo-EM through innovation in image processing, machine learning, algorithm design, and intuitive scientific workflows.
| Website | https://structura.bio/ |
| Employees | 19 (15 on RocketReach) |
| Founded | 2016 |
| Industry | Software Development |
| Keywords | Bioinformatics Software, Software Platform, Scientific Software, Data Analysis Platform, Biotechnology Software, Image Processing Software, 3d Image Processing, Molecular Visualization, Microscopy Software, Data Analysis Software, Scientific Computing, Molecular Modeling |
| Competitors | Amgen, Genentech, AbCellera, Intellia Therapeutics, Inc., Sutro Biopharma, Inc., Zymeworks Inc., Moderna Therapeutics, Proteostasis Therapeutics, Inc. (PTI), Iovance Biotherapeutics, Inc., AstraZeneca +40 more (view full list) |
Looking for a particular Structura Biotechnology employee's phone or email?
Ali Punjani is the CEO and Co-Founder of Structura Biotechnology.
15 people are employed at Structura Biotechnology.
Structura Biotechnology is based in Toronto, Ontario.